Paula Rı́o

3.6k total citations · 1 hit paper
68 papers, 2.0k citations indexed

About

Paula Rı́o is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Paula Rı́o has authored 68 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 24 papers in Genetics and 18 papers in Oncology. Recurrent topics in Paula Rı́o's work include CRISPR and Genetic Engineering (32 papers), Virus-based gene therapy research (21 papers) and DNA Repair Mechanisms (18 papers). Paula Rı́o is often cited by papers focused on CRISPR and Genetic Engineering (32 papers), Virus-based gene therapy research (21 papers) and DNA Repair Mechanisms (18 papers). Paula Rı́o collaborates with scholars based in Spain, United States and Germany. Paula Rı́o's co-authors include Juan A. Bueren, Helmut Hanenberg, Susana Navarro, Guillermo Güenechea, Jordi Surrallés, Ángel Raya, María Castellà, Gustavo Tiscórnia, Eduard Sleep and José C. Segovia and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Paula Rı́o

62 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells

2009 500 citations Ángel Raya, Guillermo Güenechea et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paula Rı́o Spain	25	1.5k	532	449	320	231	68	2.0k
Yoshihiro Takihara Japan	27	1.6k 1.1×	345 0.6×	359 0.8×	348 1.1×	301 1.3×	88	2.2k
Lee N. Lawton United States	18	1.9k 1.3×	244 0.5×	357 0.8×	397 1.2×	354 1.5×	29	2.6k
Brian S. Garrison United States	14	1.3k 0.9×	403 0.8×	248 0.6×	341 1.1×	293 1.3×	20	1.8k
Carlos‐Filipe Pereira Portugal	24	1.9k 1.3×	252 0.5×	253 0.6×	296 0.9×	119 0.5×	54	2.4k
Ewan R. Cameron United Kingdom	29	1.8k 1.2×	282 0.5×	810 1.8×	389 1.2×	471 2.0×	60	2.4k
Guillermo Güenechea Spain	20	1.3k 0.9×	586 1.1×	340 0.8×	251 0.8×	438 1.9×	42	1.9k
Loretta Cerruti Australia	21	1.1k 0.8×	309 0.6×	571 1.3×	390 1.2×	156 0.7×	28	1.8k
Huafeng Xie United States	23	2.8k 1.9×	276 0.5×	514 1.1×	717 2.2×	645 2.8×	36	3.7k
Tsuneyuki Oikawa Japan	18	1.1k 0.7×	231 0.4×	304 0.7×	390 1.2×	285 1.2×	46	1.6k
Dana N. Levasseur United States	16	1.9k 1.3×	399 0.8×	245 0.5×	88 0.3×	155 0.7×	21	2.2k

Countries citing papers authored by Paula Rı́o

Since Specialization

Citations

This map shows the geographic impact of Paula Rı́o's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Rı́o with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Rı́o more than expected).

Fields of papers citing papers by Paula Rı́o

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Rı́o. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Rı́o. The network helps show where Paula Rı́o may publish in the future.

Co-authorship network of co-authors of Paula Rı́o

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Rı́o. A scholar is included among the top collaborators of Paula Rı́o based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Rı́o. Paula Rı́o is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aparicio, Cristina, Antonio Valeri, Alejandra Leivas, et al.. (2025). A Novel Early Memory-Enriched Allogeneic NKG2D CAR-T Cell Therapy Based on CRISPR/Cas9 Technology for Solid Tumors. Cancers. 17(19). 3186–3186.

Martı́n, Francisco, Gloria Carmona, Josep M. Canals, et al.. (2025). Regulatory Strategies for Accelerating the Translation of Gene Therapies to Clinical Practice: Focus on GMO Considerations. Human Gene Therapy. 36(17-18). 1154–1158. 1 indexed citations

Tristán‐Manzano, María, et al.. (2025). Risk and Benefit Assessment of Gene Therapy with Lentiviral Vectors and Hematopoietic Stem Cells: The Skysona Case. Human Gene Therapy. 36(17-18). 1159–1172.

Castellano, Eva, Almudena García-Ortiz, Jessica Encinas, et al.. (2024). CRISPR/Cas9 Multi-Editing Enhances CAR NK Cells Therapeutic Potential Against Multiple Myeloma. Blood. 144(Supplement 1). 3442–3442. 3 indexed citations

Torres, Raúl, et al.. (2023). CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders. Cytotherapy. 25(3). 277–285. 5 indexed citations

Fernández-García, María, Begoña Díez, Jonathan Schwartz, et al.. (2022). Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I. Molecular Therapy — Methods & Clinical Development. 26. 459–470. 4 indexed citations

Loughran, Stephen J., et al.. (2021). Translational research for bone marrow failure patients. Experimental Hematology. 105. 18–21. 4 indexed citations

Bueren, Juan A., Óscar Quintana-Bustamante, Elena Almarza, et al.. (2019). Advances in the gene therapy of monogenic blood cell diseases. Clinical Genetics. 97(1). 89–102. 17 indexed citations

Roman‐Rodriguez, Francisco J, Lara Álvarez, Begoña Díez, et al.. (2019). NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia. Cell stem cell. 25(5). 607–621.e7. 69 indexed citations

10.

Leivas, Alejandra, Paula Rı́o, Almudena García-Ortiz, et al.. (2018). NKG2D-CAR Transduced Primary Natural Killer Cells Efficiently Target Multiple Myeloma Cells. Blood. 132(Supplement 1). 590–590. 24 indexed citations

11.

Rı́o, Paula, Susana Navarro, & Juan A. Bueren. (2018). Advances in Gene Therapy for Fanconi Anemia. Human Gene Therapy. 29(10). 1114–1123. 22 indexed citations

12.

Díez, Begoña, Pietro Genovese, Francisco J Roman‐Rodriguez, et al.. (2017). Therapeutic gene editing in CD 34 ⁺ hematopoietic progenitors from Fanconi anemia patients. EMBO Molecular Medicine. 9(11). 1574–1588. 44 indexed citations

13.

Rı́o, Paula, Susana Navarro, Guillermo Güenechea, et al.. (2017). Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients. Blood. 130(13). 1535–1542. 42 indexed citations

14.

Leivas, Alejandra, Antonio Valeri, Paula Rı́o, et al.. (2017). Activated and Expanded Natural Killer Cells Expressing an NKG2D-CAR Efficiently Target Multiple Myeloma Cells. Blood. 130. 4466–4466. 6 indexed citations

15.

Pulecio, Julián, Sandra Capellera-Garcia, Marianna Vitaloni, et al.. (2016). Direct Conversion of Fibroblasts to Megakaryocyte Progenitors. Cell Reports. 17(3). 671–683. 26 indexed citations

16.

Casado, José Antonio, Paula Rı́o, Esther Marco, et al.. (2008). Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin. Molecular Cancer Therapeutics. 7(5). 1309–1318. 38 indexed citations

17.

Rı́o, Paula, África González‐Murillo, Susana Navarro, et al.. (2008). In vivo proliferation advantage of genetically corrected hematopoietic stem cells in a mouse model of Fanconi anemia FA-D1. Blood. 112(13). 4853–4861. 19 indexed citations

18.

Quintana-Bustamante, Óscar, Antonio Puyet, Paula Rı́o, et al.. (2007). In Vitro and In Vivo Expression of Human Erythrocyte Pyruvate Kinase in Erythroid Cells: A Gene Therapy Approach. Human Gene Therapy. 18(6). 502–514. 5 indexed citations

19.

Schneider, L, Frank Eßmann, Paula Rı́o, et al.. (2007). TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF-mediated cell cycle arrest. Oncogene. 27(1). 116–125. 32 indexed citations

20.

Garcı́a-Castro, Javier, Paula Rı́o, Rosa Lillo, et al.. (2003). Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model. Gene Therapy. 10(16). 1328–1335. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact